Introduction
For it is then that we have need of pleasure, when we feel pain owing to the absence of pleasure. Epicurus (341-270 B.C.) [1] Anhedonia, or loss of interest or pleasure in all or almost all activities, is a prominent symptom of many neuropsychiatric disorders, most notably major depressive disorder (MDD) and schizophrenia (see Glossary) [2] . Greek philosophers, such as Epicurus, contemplated the nature of pleasure (and the absence of pleasure) over 2000 years ago. Today, however, reward-related deficits experienced by individuals with MDD, schizophrenia and other neuropsychiatric disorders involve more than just an absence or loss of pleasure. Anhedonia is a core feature of reward deficits because the capacity to feel pleasure is a critical step during the normal processing of rewards. However, having the motivation to seek out pleasurable experiences and making appropriate decisions based on those previous experiences are important processes that are equally, if not more in some cases, disturbed in individuals with MDD or schizophrenia. Deficits in these reward processes are often inappropriately labeled under the umbrella of anhedonia. The current preclinical and clinical literature regarding the neural bases of the various aspects of reward processing, and the contribution of deficits in these reward processes to the clinical symptom of anhedonia, is reviewed here.
A brief history of anhedonia Anhedonia as a psychopathological symptom was first noted in the early 19th century. Haslam, who documented the first complete study of a psychiatric patient in 1809 (suffering from schizophrenia), noted a 'neglect [of] those objects and pursuits which formerly proved sources of Review Glossary Anhedonia: markedly diminished interest or pleasure in all, or almost all, activities Avolition: a reduction or difficulty in the ability to initiate and persist in goaldirected behavior; lack of motivation. Chapman Physical and Social Anhedonia Scales (CPAS/CSAS): self-report anhedonia scales that differentiate between physical (eating, sex) and social (expressing feelings and interacting with people) pleasures. Deep brain stimulation (DBS): clinical procedure involving surgical implantation of stimulating electrodes in discrete brain sites in humans, such as the subgenual cingulate cortex, ventral striatum, inferior thalamic peduncle and lateral habenula. Subsequently, continuous stimulation of these brain sites is used to treat depression, particularly treatment-resistant depression. Diagnostic and Statistical Manual of Mental Disorders (DSM): standard classification of mental disorders published by the American Psychiatric Association and used by mental health professionals, including clinicians and researchers, in the USA. Effort Expenditure for Rewards Task (EEfRT): human experimental task used to assess motivation and effort-based decision making. Fawcett-Clark Pleasure Capacity Scale (FCPS): self-report anhedonia scale that measures the intensity of pleasurable responses with some components of anticipatory pleasure. International Classification of Diseases (ICD): the international standard diagnostic classification of diseases and other health problems published by the World Health Organization for epidemiological and health management purposes. Intracranial self-stimulation (ICSS): experimental animal procedure used to assess brain reward function. This procedure involves surgical implantation of stimulating electrodes into discrete brain sites that are part of brain reward systems. Brief electrical stimulation of these brain sites is extremely rewarding for rats and allows direct assessment of brain reward function. Please note that ICSS in experimental animals differs from DBS in humans in that: (i) ICSS involves the delivery of brief (msec) electrical pulses whereas DBS is on continuously for months or longer; (ii) ICSS is delivered on performance of an operant response by the experimental animal subject (thus the term selfstimulation) whereas DBS does not involve a discrete operant response by the patient; and (iii) according to historical and anecdotal reports, ICSS involves brief stimulation of brain sites that lead to intense feelings of pleasure in humans, whereas DBS may alleviate depressive symptoms but is not associated with intense feelings of pleasure and euphoria. The latter may be due to the discrete versus continuous nature of ICSS compared to DBS. Snaith-Hamilton Pleasure Scale (SHAPS): self-report anhedonia scale that measures hedonic responses across four domains: interests and pastimes, social interaction, sensory experience, and food and drink. Temporal Experience of Pleasure Scale (TEPS): self-report anhedonia scale that distinguishes between consummatory and anticipatory anhedonia. Trait anhedonia: anhedonia that is present in non-clinical populations or precedes the onset of psychiatric illness. Assessment of trait anhedonia in human subjects without a neuropsychiatric illness allows the dissociation of neural processes that are specific to anhedonia from confounding factors associated with the onset and progression of neuropsychiatric illnesses that include anhedonia as a symptom. Corresponding author: Markou, A. (amarkou@ucsd.edu).
